After participating in this educational activity, attendees should be able to:
1. Understand the current indications for LifeVest in the setting of acute MI and low LVEF.
2. Analyze the latest evidence surrounding the use of LifeVest for acute MI indication; specifically the VEST trial.
Amir Lotfi, MD
Associate Chief, Department of Cardiology
Jose Antonio Rodriguez-Arciniega, MD
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 BCIPE Instructional Hours